Sort
35,931 grants matching “parkinsons”
Perception and Production of Speech Timing in Parkinson's Disease
$590,026Saul Frankford · University Of Texas Dallas · R21 · FY2025 · DC
Visual Target Selection for Saccadic Eye Movements
$589,972Michele A Basso · University Of California Los Angeles · R01 · FY2020 · EY
Neurovascular Effects of Dopamine Replacement Therapy in Parkinson's Disease
$589,961David Eidelberg · Feinstein Institute For Medical Research · R01 · FY2021 · NS
Neurovascular Effects of Dopamine Replacement Therapy in Parkinson's Disease
$589,961David Eidelberg · Feinstein Institute For Medical Research · R01 · FY2022 · NS
Neurovascular Effects of Dopamine Replacement Therapy in Parkinson's Disease
$589,961David Eidelberg · Feinstein Institute For Medical Research · R01 · FY2023 · NS
Neurovascular Effects of Dopamine Replacement Therapy in Parkinson's Disease
$589,961David Eidelberg · Feinstein Institute For Medical Research · R01 · FY2020 · NS
Structure/Function Correlations Over Copper Enzymes
$589,893Edward I Solomon · Stanford University · R01 · FY2020 · DK
Akt/GSK-3 Signaling Cascade and the Actions of Dopamine
$589,795Marc G. Caron · Duke University · R37 · FY2014 · MH
Functional assessment of pathological α-syn and Aβ species in LBD
$589,777Pamela J McLean · Mayo Clinic Jacksonville · U54 · FY2019 · NS
Molecular Basis of rCGG-Mediated Neurodegeneration
$589,688Peng Jin · Emory University · R01 · FY2017 · NS
Identifying novel Parkinson'ÃÂs disease genes exploring understudied Latino populations
$589,629Ignacio Fernandez Mata · Cleveland Clinic Lerner Com-Cwru · R01 · FY2024 · NS
Identifying Drugs to Treat Age-Dependent Neurodegeneration
$589,570Kim D. Finley · Expression Drug Designs, Llc · R44 · FY2012 · AG
Software for Meta Regression
$589,557Biostatistical Programming Assoc, Inc. · R44 · FY2005 · AG
Manufacturing of Trojan Horse-TNFR Decoy Receptor Fusion Protein
$589,542Ruben J. Boado · Armagen Technologies, Inc. · R44 · FY2014 · AG
Pathophysiological Study of ALDH1A1-negative Nigrostriatal Dopaminergic Neuron Subtypes in Parkinson's disease
$589,338Huaibin Cai · National Institute On Aging · ZIA · FY2023 · AG
Stimulating Young Neuroscientists And Physiologists in Science Education - Phase
$589,300Jared Jackson · Is3d, Llc · R44 · FY2014 · MH
Neuroprotective And Neurorestorative Signaling Mechanisms
$589,281Mark Mattson · National Institute On Aging · ZIA · FY2011 · AG
Imaging Biomarkers of Freezing of Gait Response to Deep Brain Stimulation
$589,264Gonzalo Javier Revuelta · Medical University Of South Carolina · R01 · FY2025 · NS
Quality of Life for SCI Clinical Trials: Development of the SCI-QOL
$589,155David Scott Tulsky · Kessler Foundation, Inc. · R01 · FY2008 · HD
Discovering compounds with robust pro-longevity activities
$589,100Gordon J. Lithgow · Buck Institute For Research On Aging · U01 · FY2013 · AG
The role of Lamp1 and lipid transport in the regulation of vesicle identity
$589,074Andreas Jenny · Albert Einstein College Of Medicine · R01 · FY2025 · AG
Biomimetic Surface for Neural Implants
$589,066Xinyan Tracy Cui · University Of Pittsburgh At Pittsburgh · R01 · FY2016 · NS
VALIDATION OF NEUROIMAGING BIOMARKERS FOR NIGROSTRAITAL NEURONS
$588,798Joel Synes Perlmutter · Washington University · R01 · FY2016 · NS
Neural Encoding of Social Information
$588,768Joshua P Neunuebel · University Of Delaware · R01 · FY2023 · MH
COMPOUNDS ACTIVATING DJ-1 AS THERAPEUTICS FOR PARKINSON'S DISEASE
$588,696Bethany Westlund · Cambria Biosciences, Llc · R43 · FY2007 · NS